TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · no major macro event
CCCC

C4 Therapeutics Inc

Healthcare · Biotechnology

3.00$ -1.7% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Balance Sheet

C4 Therapeutics Inc (CCCC) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 359 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet CCCC
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
333 376 398 381 376 350 320 297 265 359 329 359
224 271 280 276 273 258 233 225 207 258 245 263
61 127 90 73 60 55 51 78 59 75 61 79
217 254 258 264 256 245 215 215 192 249 236 254
0.5 12 14 1.2 10 3.1 8.0 2.2 6.5 2.4 2.9 1.3
0.0 – – 0.0 – – – – – – – –
117 130 140 134 133 134 124 122 111 102 95 112
30 43 55 54 43 45 41 44 36 33 27 48
5.1 5.2 5.4 5.5 5.6 5.8 5.9 6.1 6.2 6.4 6.5 6.7
1.3 1.4 1.6 0.9 1.5 1.3 0.7 2.2 1.3 0.9 0.8 1.1
216 246 258 247 243 216 195 174 154 257 234 247
-494 -528 -557 -574 -599 -634 -660 -686 -718 -739 -764 -787
49 51 68 69 70 71 71 71 73 117 126 131

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?